H-share Movement | Ark Jankang (06086) surged over 5% in the morning session amid the company's accelerated fundraising to develop an AI-driven chronic disease management platform, following the recent release of a positive profit forecast.

Fangzhou Jianke (06086) surged over 5% in the morning session. As of the time of writing, it was up 5.1%, trading at HKD 2.68 with a turnover of HKD 111 million.

Zhitong FinanceFeb 5 22:47 ET

Fangzhou Jianke (06086) completed the placement of 45,181,000 shares on a 'top-up' basis, raising approximately HKD 144.3 million in net proceeds.

Fangzhou Jianke (06086) announced that the completion of the placement was finalized on January 29, 2026, and the completion of the subscription was finalized on February 2, 2026. According to the terms and conditions of the placement and subscription agreement, a total of 45,181,000 placement shares were successfully placed by the placing agent at a placement price of HKD 3.32 per share to no fewer than six placees.

Zhitong FinanceFeb 2 08:13 ET

Fangzhou Plans to Use Around 90% of Net Proceeds to Accelerate Development of AI-Driven Chronic Care Platform >6086.HK

Dow JonesJan 26 22:52 ET

Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit

GlobeNewswireJan 26 22:40 ET

Fangzhou Jianke Plummets Nearly 19% as Rights Issue Pressure Offsets First Full-Year Profit

① What specific areas will the net proceeds of HKD 1.44 billion raised by Ark Jianke's "old-to-new" placement be allocated to? ② How do institutions perceive the future development of internet healthcare?

cls.cnJan 26 21:48 ET

Express News | Fangzhou Inc - to Place 45.2 Mln Shares at HK$3.32 per Share

ReutersJan 26 19:03 ET